3 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Interferon-alpha2b: new trials by email Literature Review of Interferon-alpha2b trials Research Report on Interferon-alpha2b
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) Interferon-Alpha2B, Placebo - Coronavirus Disease 2019 | Phase 1 / Phase 2 | Completed | Pontificia Universidad Catolica de Chile | 173 | 2021-09-15 | 2022-08-05 |
| The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol Hydroxychloroquine, Azithromycin, Hydroxychloroquine, Doxycycline, Hydroxychloroquine, Clindamycin - CoVid 19 Positive | Phase 2 / Phase 3 | Completed | The Camelot Foundation | 1800 | 2020-04-11 | 2020-11-12 |
| Nordic Adjuvant IFN Melanoma Trial Interferon-alpha2b - 1 year, Interferon-alpha2b - 2 years - Melanoma, Adjuvant Therapy | Phase 3 | Completed | Karolinska Institutet | 855 | 1996-11-01 | 2010-12-14 |
Karolinska Institutet (1) · Pontificia Universidad Catolica de Chile (1) · The Camelot Foundation (1)
Chile (1) · Sweden (1) · United States (1)
Arturo Borzutzky, M.D. (1) · Carolina Iturriaga, R.N. (1) · Eleanor Fish, Ph.D. (1) · Hans von der Maase, MD PhD (1) · Johan Hansson, MD,PhD (1) · Lars Bastholt, MD,PhD (1) · Micaela Hernberg, MD, PhD (1) · Richard M Fleming, PhD, MD, JD (1) · Steinar Aamdal, MD. PhD (1) · Ulrika Stierner, MD PhD (1)